LINDAHL RICHARD S 4
4 · Emergent BioSolutions Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
LINDAHL RICHARD S
EVP, Chief Financial Officer
Transactions
- Award
Employee Stock Options (Right to Buy)
2024-03-13+125,000→ 305,944 totalExercise: $2.33Exp: 2031-03-12→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.